Increasing white matter hyperintensity volume load may be associated with recurrent stroke after ischemic or hemorrhagic stroke, and with 1-year mortality after ischemic stroke.
Antiepileptic drugs such as phenytoin, levetiracetam, and valproic acid may not result in improvements in neurologic outcomes or reductions in seizure activity in patients with spontaneous intracerebral hemorrhage.
Low-dose aspirin use for primary prevention of cardiovascular events in people without symptomatic cardiovascular disease was associated with an increased risk for intracranial hemorrhage.
The MISTIE procedure plus rtPA was associated with significantly decreased ICH volumes compared with the medical group.
In the linear analysis, study investigators found no significant effect of magnesium on cognition.
Serum lactate at admission did not correlate with vasospasm or delayed cerebral ischemia development.
One in 8 patients with ACI experience ultra-early neurological deterioration during ambulance transport and initial evaluation at the emergency department.
A team of investigators sought to assess the efficacy and safety of cilostazol vs aspirin, both with and without probucol, a cholesterol-lowering agent, in Asian patients with ischemic stroke.
Investigators assessed the presence of cerebral microbleeds as a biomarker for identifying patients at increased risk for intracranial hemorrhage as a result of anticoagulation for atrial fibrillation.
Black and Hispanic patients are at higher risk for stroke recurrence than white patients.
